← FDA Drug Approvals (Drugs@FDA)

HALOBETASOL PROPIONATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PADAGIS ISRAEL · Approved 2023-08-11

Drug application

FDA Application #

ANDA215266

Application type

Abbreviated New Drug Application (Generic)

Brand name

HALOBETASOL PROPIONATE

Generic name

HALOBETASOL PROPIONATE

Active ingredients

HALOBETASOL PROPIONATE

Dosage form

AEROSOL, FOAM

Route

TOPICAL

Marketing status

Prescription

Sponsor

PADAGIS ISRAEL

Manufacturer

Mayne Pharma

First approval

2023-08-11

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown